ESC 365 - Lipid management among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes

ESC Professional Premium Access

Lipid management among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes

Session: Diabetes as a risk factor for heart disease

Topic: Lipids

Speaker: Doctor S. Shoji (Durham, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Satoshi Shoji

Duke Clinical Research Institute, Durham (United States of America)

0 follower

8 more presentations in this session

Prediction of cardiovascular risk in patients type 2 diabetes using the SCORE2-Diabetes risk score

Speaker: Associate Professor M. Cavender (Chapel Hill, US)

DNA methylation in the TXNIP gene is associated with type 2 diabetes in Pacific Peoples living in NZ

Speaker: Mr S. Gibbs (Christchurch, NZ)

Prognostic implications of right and left atrial strain in diabetes mellitus without coronary artery diseases.

Speaker: Professor M. Matshela (Durban, ZA)

Subgroup analysis of diabetes in COVID-positive revascularized patients: implications for clinical management

Speaker: Doctor Z. Alimli (Baku, AZ)

The visceral adiposity index predicts cardiovascular events both in coronary artery disease patients with and in those without diabetes

Speaker: Associate Professor H. Drexel (Feldkirch, AT)

Access the full session

Diabetes as a risk factor for heart disease

Speakers: Doctor S. Shoji, Associate Professor M. Cavender, Mr S. Gibbs, Professor M. Matshela, Doctor Z. Alimli...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources